The global incidence of basal cell carcinoma is increasing due to prolonged exposure to ultraviolet (UV) radiation, genetic predispositions, and an aging population that is more susceptible to skin ...

A new study led by researchers at the Johns Hopkins Kimmel Cancer Center found that patients with advanced basal cell carcinoma (BCC) may benefit from receiving immunotherapy earlier in the course of ...

The basal cell carcinoma market is expected to expand over the next decade as rising diagnoses, aging populations and increased UV exposure lift demand. DelveInsight estimates the global market at ...

Durable, ongoing near-complete response to nivolimab + relatlimab in a 64 year old with locally-advanced BCC after resistance to 26 wks of nivolimab alone. A new study led by researchers at the Johns ...

The Oxford dictionary defines a tumour as “any abnormal swelling in or on a part of the body”. They develop in nearly any ...

The terms tumor and cancer can refer to different types of lumps and bumps. But the terms are often confused and misused—by ...

Keytruda plus platinum-based chemotherapy was found to be both safe and efficacious in treating penile squamous cell carcinoma (PSCC), according to findings from the phase 2 HERCULES trial presented ...

Metropolitan Dermatology, a leading dermatology group with 22 locations across New Jersey and Staten Island, is pleased to announce that it now offers same-day appointments at most of its centers, ...

The Oxford dictionary defines a tumour as “any abnormal swelling in or on a part of the body”. They develop in nearly any ...

The immunotherapies used to treat melanoma now include well-established drugs such as Keytruda (pembrolizumab) and Opdivo (nivolumab) and newer ones such as Amtagvi (lifileucel), which uses T cells ...

PHILADELPHIA, PA / ACCESS Newswire / December 5, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a ...